Viewing Study NCT01585805


Ignite Creation Date: 2025-12-25 @ 3:32 AM
Ignite Modification Date: 2026-01-09 @ 6:06 PM
Study NCT ID: NCT01585805
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-03-11
First Post: 2012-04-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module